Changes of CD4+CD25+FOXP3 + and CD8+CD28 - Regulatory T cells in non-small cell lung cancer patients undergoing surgery

International Immunopharmacology

Volumn 18, Issue 2, 2014, Pages 255-261

  Chen, Cheng ^a   Chen, Dongdong ^a   Zhang, Yongkui ^a   Chen, Zhijun ^a   Zhu, Wangyu ^a   Zhang, Binjie ^a   Wang, Zhaoye ^a   Le, Hanbo ^a  

^a Zhoushan Hospital   (China)

Author keywords

CD4+CD25+FOXP3 +; CD8+CD28 ; NSCLC; Surgery; Treg

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CD4+CD25+FOXP3+ REGULATORY T LYMPHOCYTE; CD8+CD28- REGULATORY T LYMPHOCYCTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

CD4+CD25+FOXP3+; CD8+CD28-; NSCLC; SURGERY; TREG;

AGED; ANTIGENS, CD28; ANTIGENS, CD4; ANTIGENS, CD8; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; T-LYMPHOCYTES, REGULATORY;

EID: 84891671343     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.12.004     Document Type: Article

References (34)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90 [PubMed: 21296855]
2. T.S. Mok, Y.L. Wu, S. Thongprasert, C.H. Yang, D.T. Chu, and N. Saijo et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 10 2009 947 957 [PubMed: 19692680]
3. M. Maemondo, A. Inoue, K. Kobayashi, S. Sugawara, S. Oizumi, and H. Isobe et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 25 2010 2380 2388 [PubMed: 20573926]
4. A. Sandler, J. Yi, S. Dahlberg, M.M. Kolb, L. Wang, and J. Hambleton et al. Treatment outcomes by tumor histology in Eastern Cooperative Group Study E4599 of bevacizumab with paclitaxel/carboplatin for advanced non-small cell lung cancer J Thorac Oncol 5 9 2010 1416 1423 [PubMed: 20686429]
5. M. Terabe, and J.A. Berzofsky Immunoregulatory T cells in tumor immunity Curr Opin Immunol 16 2 2004 157 162 [PubMed: 15023407] (Pubitemid 38332026)
6. W.Z. Wei, G.P. Morris, and Y.C. Kong Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells Cancer Immunol Immunother 53 2 2004 73 78 [PubMed: 14610619] (Pubitemid 38161212)
7. N. Najafian, T. Chitnis, A.D. Salama, B. Zhu, C. Benou, and X. Yuan et al. Regulatory functions of CD8+CD28 - T cells in an autoimmune disease model J Clin Invest 112 2003 1037 1048 [PubMed: 14523041] (Pubitemid 38056319)
8. G. Filaci, M. Fravega, S. Negrini, F. Procopio, D. Fenoglio, and M. Rizzi et al. Nonantigen specific CD8 + T suppressor lymphocytes originate from CD8+CD28 - T cells and inhibit both T-cell proliferation and CTL function Hum Immunol 65 2004 142 156 [PubMed: 14969769] (Pubitemid 38224140)
9. H. Kawaida, K. Kono, A. Takahashi, H. Sugai, K. Mimura, and N. Miyagawa et al. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer J Surg Res 124 1 2005 151 157 [PubMed: 15734494] (Pubitemid 40269816)
10. S. Sakaguchi Naturally arising CD4 + regulatory t cells for immunologic self-tolerance and negative control of immune responses Annu Rev Immunol 22 2004 531 562 [PubMed: 15032588] (Pubitemid 38680433)
11. W. Zou Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat Rev Cancer 5 4 2005 263 274 [PubMed: 15776005] (Pubitemid 40488632)
12. S. Hori, T. Nomura, and S. Sakaguchi Control of regulatory T-cell development by the transcription factor FOXP3 Science 299 2003 1057 1061 [PubMed: 12522256] (Pubitemid 36222930)
13. R. Okita, T. Saeki, S. Takashima, Y. Yamaguchi, and T. Toge CD4+CD25 + regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer Oncol Rep 14 5 2005 1269 1273 [PubMed: 16211295]
14. M. Beyer, and J.L. Schultze Regulatory T cells in cancer Blood 108 2006 804 811 [PubMed: 16861339] (Pubitemid 44154611)
15. M. Beyer, M. Kochanek, T. Giese, E. Endl, M.R. Weihrauch, and P.A. Knolle et al. In vivo peripheral expansion of naive CD4+CD25high FoxP3 + regulatory T cells in patients with multiple myeloma Blood 107 2006 3940 3949 [PubMed: 16410445] (Pubitemid 43726800)
16. L.A. Ormandy, T. Hillemann, H. Wedemeyer, M.P. Manns, T.F. Greten, and F. Korangy Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma Cancer Res 65 2005 2457 2464 [PubMed: 15781662] (Pubitemid 40490158)
17. T.J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng, and P. Mottram et al. Specific recruitment of regulatory T-cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Nat Med 10 2004 942 949 [PubMed: 15322536] (Pubitemid 39273735)
18. J. Fu, D. Xu, Z. Liu, M. Shi, P. Zhao, and B. Fu et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients Gastroenterology 132 7 2007 2328 2339 [PubMed: 17570208] (Pubitemid 46890865)
19. F. Meloni, M. Morosini, N. Solari, I. Passadore, C. Nascimbene, and M. Novo et al. FOXP3 expressing CD4+CD25 - and CD8+CD28 - T regulatory cells in the peripheral blood of patients with lung cancer and pleural mesothelioma Hum Immunol 67 2006 1 12 [PubMed: 16698419] (Pubitemid 43673918)
20. K. Chikamatsu, K. Sakakura, T.L. Whiteside, and N. Furuya Relationships between regulatory T cells and CD8 + effector populations in patients with squamous cell carcinoma of the head and neck Head Neck 29 2 2007 120 127 [PubMed: 17103408] (Pubitemid 46167778)
21. G. Filaci, D. Fenoglio, M. Fravega, G. Ansaldo, G. Borgonovo, and P. Traverso et al. CD8 + CD28 - T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers J Immunol 179 2007 4323 4334 [PubMed: 17878327]
22. Q. Gao, S.J. Qiu, J. Fan, J. Zhou, X.Y. Wang, and Y.S. Xiao et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection J Clin Oncol 25 18 2007 2586 2593 [PubMed: 17577038] (Pubitemid 47041232)
23. W.Y. Kim, Y.K. Jeon, T.M. Kim, J.E. Kim, Y.A. Kim, and S.H. Lee et al. Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma Ann Oncol 20 10 2009 1688 1696 [PubMed: 19542249]
24. R. Nakamura, M. Sakakibara, T. Nagashima, T. Sangai, M. Arai, and T. Fujimori et al. Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer Eur J Cancer 45 12 2009 2123 2131 [PubMed: 19398324]
25. A.M. Miller, K. Lundberg, V. Ozenci, A.H. Banham, M. Hellström, and L. Egevad et al. CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients J Immunol 177 10 2006 7398 7405 [PubMed: 17082659] (Pubitemid 44715110)
26. T. Yaguchi, H. Sumimoto, C. Kudo-Saito, N. Tsukamoto, R. Ueda, and T. Iwata-Kajihara et al. The mechanisms of cancer immunoescape and development of overcoming strategies Int J Hematol 93 2011 294 300 [PubMed: 21374075]
27. G.A. Rabinovich, D. Gabrilovich, and E.M. Sotomayor Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 25 2007 267 296 [PubMed: 17134371] (Pubitemid 46697910)
28. K. Kono, H. Kawaida, A. Takahashi, H. Sugai, K. Mimura, and N. Miyagawa et al. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers Cancer Immunol Immunother 55 2006 1064 1071 [PubMed: 16328385] (Pubitemid 43800721)
29. Y.X. Wang, W.L. Su, and W.X. Zhu Correlation of the changes of lymphocyte phenotype to tumor stage and operative pattern of gastric cancer Ai Zheng 23 2004 1065 1068 [PubMed: 15363203]
30. M.M. Corsi, D. Pagani, E.L. Iorio, G. Dogliotti, R. Verna, and G. Sambataro et al. Blood reactive oxygen metabolites (ROMs) and total antioxidant status (TAS) in patients with laryngeal squamous cell carcinoma after surgical treatment Clin Chem Lab Med 44 2006 1047 1048 [PubMed: 16879077] (Pubitemid 44155879)
31. V.K. Todorova, V.S. Klimberg, L. Hennings, T. Kieber-Emmons, and A. Pashov Immunomodulatory effects of radiofrequency ablation in a breast cancer model Immunol Invest 39 1 2010 74 92 [PubMed: 20064086]
32. Y. Saito, M. Shimada, T. Utsunomiya, Y. Morine, S. Imura, and T. Ikemoto et al. Regulatory T cells in the blood: a new marker of surgical stress Surg Today 43 6 2013 608 612 [PubMed: 23412515]
33. H.J. Gao, Y.J. Zhang, H.H. Liang, P. Li, Z.W. Peng, and X.H. Pang et al. Radiofrequency ablation does not induce the significant increase of CD4+CD25+FOXP3 + regulatory T cells compared with surgical resection in Hepal-6 tumor model Arch Immunol Ther Exp (Warsz) 61 4 2013 333 340 [PubMed: 23595594]
34. J.A. Bluestone, and A.K. Abbas Natural versus adaptive regulatory T cells Nat Rev Immunol 3 3 2003 253 257 [PubMed: 12658273] (Pubitemid 37323210)